Premier Alternatives

Syenex

Evanston, IL · Founded 2022 · Privately Held (backing)

Developer of bioengineering technologies designed to improve the precision and effectiveness of therapeutic cell engineering. Syenex is based in Evanston, IL and was founded in 2022. It was valued at $22 million at its seed round in Jan 2025, the last priced event on record. It has raised $13.7 million across 2 recorded rounds; the latest was an $8.7 million early-stage round in Jan 2025.

PMV mark · valuation
$22.0M
Oct 2026
Priced at
its seed round
Jan 2025
Total raised
$13.7M
Last round
Early Stage VC
Jan 2025

Syenex key facts

as of Oct 2026
  • Developer of bioengineering technologies designed to improve the precision and effectiveness of therapeutic cell engineering.
  • Syenex is valued at approximately $22.0M as of Oct 2026, set at its seed round, Jan 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $13.7M across 2 recorded rounds; the latest was Early Stage VC ($8.7M) in Jan 2025.
  • Notable investors include MedTech Innovator, AlleyCorp, Lightbank (Venture Capital), Constellation Technology Ventures, KdT Ventures — 9 tracked in total.
  • Syenex has filed 3 Form Ds with the SEC since 2022, most recently Jan 2025 ($8.7M sold to 18 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$22.0M

Valued at $22.0M at its seed round, Jan 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Syenex with a free account
  • ·Watch Syenex: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Syenex funding rounds

2 rounds
Jan 2025Early Stage VC$8.7MSEC filing▮
Jun 2022Early Stage VC$5.0MSEC filing▮
Full funding history →

Syenex valuation

Syenex was valued at $22 million at its seed round in Jan 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Syenex raised?

Syenex has raised $13.7 million across 2 recorded rounds since 2022. The largest was an $8.7 million early-stage round in Jan 2025.

Syenex has filed 3 Form Ds with the SEC since 2022, most recently in Jan 2025 ($8.7 million sold to 18 investors).

Syenex investors

9 investors are on record for Syenex, including MedTech Innovator, AlleyCorp, Lightbank (Venture Capital) and Constellation Technology Ventures. The early-stage round in Jan 2025 drew 18 investors.

About Syenex

Developer of bioengineering technologies designed to improve the precision and effectiveness of therapeutic cell engineering. The company offers optimized enveloped vector surface compositions, programmable payload-compatible delivery systems, scalable manufacturing integrations, and regulatory support services, enabling drug developers and biotechnology researchers to create advanced medicines with greater efficiency and reliability.

Sector
Healthcare
HQ
Evanston, IL, United States
Founded
2022
Employees
8
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.